视网膜缺血再灌注损伤机制研究进展

Advances in the mechanism of retina ischemia-reperfusion injury

Retinal ischemia-reperfusion injury(RIRI)is a common cause of visual impairment and blindness.At the cellular level,ischemic and reperfuion retinal injury consists of a self-reinforcing destructive cascade involving oxidative stress initiated by energy failure,inflammatory reaction,calcium influx,increased glutamatergic stimulation and neuronal depolarisation and apoptosis.A number of animal models and analytical techniques have been used to study the retinal ischemia-reperfusion injury,we now understand much better than ever before in the mechanism of RIRI,and an increase in the therapeutic strategies has been developed experimentally to attenuate the detrimental effects of retinal ischemia-reperfusion injury.Thus far,however,success in the laboratory has not been translated to the clinic.Given the increasing understanding of the events involved in ischemia-reperfusion neuronal injury,it is hoped that clinically effective treatments for retinal ischemia-reperfusion injury will soon be available.

Retinal ischemla- reperfusion injury （BIBI） is a common cause of visual impairment and blindness. At the cellular level, ischemic and reperfuion retinal injury consists of a self - reinforcing destructive cascade involving oxidative stress initiated by energy failure, inflammatory reaction, calcium influx, increased glutamatergic stimulation and neuronal depolarisation and apoptosis. A number of animal models and analytical techniques have been used to study the retinal ischemia - reperfusion injury, we now understand much better than ever before in the mechanism of BIB.I, and an increase in the therapeutic strategies has been developed experimentally to attenuate the detrimental effects of retinal ischemia - reperfusion injury. Thus far, however, success in the laboratory has not been translated to the clinic. Given the increasing understanding of the events involved in ischemia - reperfusion neuronal injury, it is hoped that clinically effective treatments for retinal ischemiareperfusion injury will soon be available.